IRCT20170527034146N2CompletedPhase 2
Evaluation of the occurrence, effect and side effects oFcyclophosfamid and rituximab in the tratment of children with NEPHROTIC SYNDROM resistance to STEROID that referred to Hazrate Massumeh hospital .
Ghoum University of Medical Sciences0 sites102 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 102
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 year to 18 years (—)
- Sex
- All
Inclusion Criteria
- •?All patient whit nephrotic syndrome resistance to steroid whit age 1-18 yr
Exclusion Criteria
- •All patient who do not have steroid-resistant Nephrotic Syndrome for example patient with steroids depended syndrome.
- •All patient who did not accept treatment
- •All patient who died
- •All patient who did not follow up
Investigators
Similar Trials
Recruiting
Phase 4
Evaluation the possible side effects of rivaroxaban in patients with pulmonary valve replacement or Fontan surgery.IRCT20220516054868N2Esfahan University of Medical Sciences75
Completed
Phase 3
Effect of glucosamine in the treatment of psoriasisPsoriasis vulgarisIRCT20200817048439N1Mashhad University of Medical Sciences30
Not yet recruiting
Phase 3
Evaluation of the effect of Medvac IVIg on PIDPrimary immunodeficiency disorder.D84.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.D84.9IRCT20101012004920N9Medvac BioPharma Company50
Completed
Not Applicable
Effect of anterior chamber paracentesis to control the pressure of the eye after cataract surgeryAge-related cataractIRCT20091030002647N2Kerman University of Medical Sciences68
Completed
Not Applicable
Examination of the adverse event related to influenza virus vaccines in children with idiopathic nephrotic syndromeidiopathic nephrotic syndromeJPRN-UMIN000028658Kakogawa central city hospital40